ESR1 and ductal breast carcinoma in situ: According to the latest recommendation, cases with an ER positivity of ≥1 and ≤10% should be classified into a new diagnostic category of “low positive/weakly positive” [The low positive designation applies only to invasive carcinoma and ER, and is not used for PR or DCIS (71, 72)].